The potential mechanism of treating IC/BPS with hyperbaric oxygen by reducing vascular endothelial growth inhibitor and hypoxia-inducible factor-1α
Turkish Journal of Medical Sciences · 01.01.2024 · 54 (1) · 26-32
DOI: 10.55730/1300-0144.5762 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Medical Sciences, online erschienen am 01.01.2024. Verfasst von Jing Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hyperbaric Oxygen, Capital Medical University, Beijing Chao-Yang Hospital, Beijing, China. Hauptthemen laut MEDLINE: Hyperbaric Oxygenation, Hypoxia-Inducible Factor 1, alpha Subunit, Cystitis, Interstitial. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
To investigate the roles of vascular endothelial growth inhibitor (VEGI) and hypoxia-inducible factor-1α (HIF-1α) in the treatment of refractory interstitial cystitis/bladder pain syndrome (IC/BPS) with hyperbaric oxygen (HBO).Materials and methods: A total of 38 patients were included. They were assessed before and 6 months after HBO treatment. Three- day voiding diaries were recorded, and O’leary-Sant scores, visual analog scale (VAS) scores, quality of life (QoL) scores, pelvic pain, and urgency/frequency (PUF) scores were evaluated. Bladder capacity was assessed by cystoscopy. Bladder mucosa was collected for Western blot, qRT-PCR, and immunofluorescence staining to compare the expression of VEGI and HIF-1α before and after treatment.
Results
Compared with before treatment, patients showed significant improvements in 24-h voiding frequency (15.32 ± 5.38 times), nocturia (3.71 ± 1.80 times), O’leary-Sant score (20.45 ± 5.62 points), VAS score (41.76 ± 17.88 points), QoL score (3.03 ± 1.44 points), and PUF score (19.95 ± 6.46 points) after treatment (p < 0.05). There was no significant difference in bladder capacity before and after treatment (p ≥ 0.05). The expression levels of VEGI and HIF-1α protein and mRNA were significantly decreased 6 months after treatment compared with before treatment. Immunofluorescence staining results showed that the double positive expression of VEGI and HIF-1α protein in bladder tissue of IC/BPS patients after HBO treatment quantitatively decreased significantly.
Conclusion
This study identified a possible mechanism by whic decreased after HBO treatment due tohypoxia reversal, which improved symptoms in IC/BPS patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hyperbaric Oxygen, Capital Medical University, Beijing Chao-Yang Hospital, Beijing, China.
- Department of Pathology, Fourth Medical Centre of Chinese People's Liberation Army General Hospital, Beijing, China.
- Department of Urology, Capital Medical University, Beijing Chao-Yang Hospital, Beijing, China.
ORCID-Profile: Jing Zhang, Jiarui Kang, Liyang Wu
Zitieren
APA
Zhang, J., Kang, J., & Wu, L. (2024). The potential mechanism of treating IC/BPS with hyperbaric oxygen by reducing vascular endothelial growth inhibitor and hypoxia-inducible factor-1α. Turkish Journal of Medical Sciences, 54(1), 26-32. https://doi.org/10.55730/1300-0144.5762
Vancouver
Zhang J, Kang J, Wu L. The potential mechanism of treating IC/BPS with hyperbaric oxygen by reducing vascular endothelial growth inhibitor and hypoxia-inducible factor-1α. Turkish Journal of Medical Sciences. 2024;54(1):26-32. doi:10.55730/1300-0144.5762
BibTeX
@article{Zhang2024,
author = {Zhang, Jing and Kang, Jiarui and Wu, Liyang},
title = {The potential mechanism of treating IC/BPS with hyperbaric oxygen by reducing vascular endothelial growth inhibitor and hypoxia-inducible factor-1α},
journal = {Turkish Journal of Medical Sciences},
year = {2024},
volume = {54},
number = {1},
pages = {26--32},
doi = {10.55730/1300-0144.5762}
}
EUVIMED